Human dopamine transporter gene: Coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations

Molecular Psychiatry

Volumn 5, Issue 3, 2000, Pages 283-292

  Vandenbergh, D J ^a   Thompson, M D ^a   Cook, E H ^b   Bendahhou, E ^b   Nguyen, T ^c   Krasowski, M D ^c   Zarrabian, D ^d   Comings, D ^e   Sellers, E M ^f   Tyndale, R F ^a   George, S R ^g   O'Dowd, B F ^e   Uhl, G R ^a,g  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF CHICAGO   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Chromosome 5p15.3; Polymorphism; Psychiatric disorder; Sequence; Transmission disequilibrium test

Indexed keywords

ALCOHOL; COCAINE; DOPAMINE TRANSPORTER; PSYCHOSTIMULANT AGENT;

ALCOHOLISM; ARTICLE; ATTENTION DEFICIT DISORDER; DOPAMINERGIC TRANSMISSION; DRUG TARGETING; EXON; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC CONSERVATION; GENETIC POLYMORPHISM; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPERACTIVITY; INTRON; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SYNAPSE; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 0004883390     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000701     Document Type: Article

References (46)

1. Uhl GR, Johnson PS. Neurotransmitter transporter: three important gene families for neuronal function. /Exp Biol 1994; 196: 229-236.
2. Ritz MC, Lamb RJ, Goldberg SR, Kukor MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987; 237: 1219-1223.
3. Singer HS, Hahn I-H, Moran T. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann Neural 1991; 30: 558-5C2.
4. Wong DF, Harris JC, Naidu S, Yokoi F, Marenco S, Dannals RF et al. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc Natl Acad Sci 199G; 93: 5539-5543.
5. Wong DF, Ricaurte G, Gründer G, Rothman R, Naidu S, Singer H et al. Dopamine transporter changes in neuropsychiatrie disorders. AdvPharm 1998; 42: 219-223.
6. G Uhl GR, Lin Z, Metzger T, Dar D. Dopamine transporter mutants, small molecules, and approaches to cocaine antagonist/dopamine transporter disinhibiter development. Met Enz 1998; 296: 45G-4G5.
7. Gainetdinov RR, Fumagalli F, Jones SR, Caron MG. Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter. / Neurochem 1997; 69: 1322-1325.
8. Giros B, Jaber M. Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1990; 379: 606-612.
9. Sora I, Wichems C, Takahashi N, Li X-F, Zeng Z, Rcvay R et al. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci 1998; 93: 7099-7704.
10. Cook EHJ, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE et al. Association of attention-defect disorder and the dopamine transporter gene. Am J Hum Genet 1995; 56: 993-998.
11. Waldman ID, Rowe DC, Abramowitz A, Kozel S, Mohr J, Sherman SL et al. Association and linkage of the dopamine transporter gene and attention-deficit hypcractivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet 1998; 63: 1767-1776.
12. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 1997; 2: 311-313.
13. Daly G, Hawi Z, Fitzgerald M, Gill M. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DDH and DRD5 to affected children. Mol Psychiatry 1999; 4: 192-196.
14. LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit-hyperactivity disorder. Mol Psychiatry 1990; 1: 121-124.
15. Gelernter J, Kranzler HR, Satel SL, Rao PA. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychoparmacology 1994; 11: 195-200.
16. IG Kelsoe J, Sadovnick AD, Kristbjarnarson H, Bergesch P, Mroczkowski-Parker Z, Drennan M et al. Possible locus for bipolar disorder near the dopamine transporter on chromosome 5. Am J Med Genet 1996; 67: 533-540.
17. Schmidt LG, Harms H, Kuhn S, Rommelspacher H, Sander T. Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. Am ] Psychiatry 1998; 155: 474-478.
18. Persico AM, Vandenbergh DJ, Smith SS, Uhl GR. Dopamine transporter gene markers are not associated with polysubstance abuse. Biol Psychiatry 1993; 34: 265-267.
19. Muramatsu T, Higuchi S. Dopamine transporter gene polymorphism and alcoholism. Biochem Biophys B.es Com 1995; 211: 28-32.
20. Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A et al. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol Psychiatry 1997; 41: 299-304.
21. Daniels J, Williams JD, Asherton P, McGuffin P, Owen M. No association between schizophrenia and polymorphisms within the genes for debrisoquine 4-hydroxylase (CYP2D6) and the dopamine transporter (DAT). Am J Med Gen 1995; 60: 85-87.
22. Persico AM, Wang ZW, Black DW, Andreasen NC, Uhl GR, Crowe . RR. Exclusion of close linkage of the dopamine transporter gene with schizophrenia spectrum disorders. Am J Psychiatry 1995; 152: 134-13G.
23. Comings DE, Wu S, Chui C, Ring RH, Gade R, Ahn C et al. Polygenetic inheritance of Tourette's syndrome, stuttering, attention defect hyperactivity, conduct and oppositional defiant disorder: the addi-live and subtractive effect of the three dopaminergic genes-DRD2, DBH, and DAT1. Am ] Med Genet 199G; 67: 264-288.
24. Higuchi S, Muramatsu T, Aral H, Hayashida M, Sasaki H, Trojanowski JQ. Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease. J Neural Transm 1995; 10: 107-113.
25. LeCouteur DG, Leighton PW, McCann SJ, Pond SM. Association of a polymorphism in the dopamine transporter gene with Parkinson's disease. Mov Disord 1997; 12: 760-763.
26. Leighton PW, LeCouteur DG, Pang CC, McCann SJ, Chan D, Law LK et al. The dopamine transporter gene and Parkinson's disease in a Chinese population. Neurology 1997; 49: 1577-1579.
27. Donovan DM, Vandenbergh DJ, Perry MP, Bird GS, Ingersoll R, Nanthakumar E et al. Human and mouse dopamine transporter genes: conservation of 5'-flanking sequence elements and gene structures. Am J Med Genet 1995; 3: 327-335.
28. Vandenbergh DJ, Persico AM, Uhl GR. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic Taq I RFLPs. Mol Brain fles 1992; 15: 161-16G.
29. Tyndale RM, Droll KP, Sellers EM. Genetically defined CYP2D6 metabolism provides protection against oral opiate dependence. Pharmacogenetics 1997; 7: 375-379.
30. Smith SS, O'Hara BF, Persico AM, Gorelick DA, Newlin DB, Vlahov D et al. Genetic vulnerability to drug abuse: the dopamine D2 receptor TaqI Bl RFLP appears more frequently in polysubstance abusers. Arch Gen Psychiatry 1992; 49: 723-727.
31. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association: Washington DC, 1987.
32. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am ] Hum Genet 1993; 52: 506-516.
33. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992; 14: 1104-1106.
34. Bardeesy N, Pelletier J. Mutational detection by single stranded conformational polymorphism. Meth Neurosci 1995; 26: 163-183.
35. Thompson M, Comings DE, Feder L, George SR, O'Dowd BF. Mutation screening of the dopamine Dl receptor gene in Tourette's syndrome and alcohol dependent patients. Am ] A/erf Genet 1998; 81: 241-244.
36. Kawarai T, Kawakami H, Yamamura Y, Nakamura S. Structure and organization of the gene encoding human dopamine transporter. Gene 1997; 195: 11-18.
37. Porzgen P, Bonisch H, Brass M. Molecular cloning and organization of the coding region of the human norepinephrine transporter gene. Biochem Biophys Res Com 1995; 215: 1145-1150.
38. Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL et al. Organization of the human serotonin transporter gene. / Neural Transm 1994; 95: 157-162.
39. Liu QR, Mandiyan S, Nelson H, Nelson N. A family of genes encoding neurotransmitter transporters. Proc Natl Acad Sci 1992; 89: 6639-6643.
40. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994; 265: 2037-2048.
41. Uhl GR, Gold LH, Risch N. Genetic analyses of complex behavioral disorders. Proc Natl Acad Sci 1997; 94: 2785-2786.
42. Falconer DS. Introduction to Quantitative Genetics, 3rd edn. John Wiley & Sons: New York, 1989, p 1.
43. Abrams ES, Murdaugh SE, Lerman LS. Comprehensive detection of single base changes in human genomic DNA using denaturing gradient gel electrophoresis and a GC clamp. Genomics 1990; 7: 463-475.
44. Tishkoff SA, Dietzsch E, Speed W, Pakstis AJ, Kidd JR, Cheung K et al. Global patterns of linkage disequilibrium at the CD4 locus and modern human origins. Science 1996; 271: 1380-1387.
45. Tiihonen J, Kuikka J, Bergstrom K, Hakola P, Karhu J, Ryynanen O-P et al. Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nature Med 1995; 1: 654-657.
46. Cook EJ, Stein MA, Leventhal BL. Family-based association of the dopamine transport gene in attention deficit disorder. In: Blum K, Nobel EP (eds). Handbook of Psychiatric Genetics. CRC Press: New York, 1997, pp297-310.